RNA sequencing can serve to characterize the composition and function of EVs, as well as identify novel biomarkers and therapeutic targets. Creative Biolabs offers RNA sequencing and profiling services for multiple types of RNA in EVs, including transcriptome, miRNA, mRNA, lncRNA, and circRNA.
The investigation of the whole transcriptome of EVs in RNA sequencing enables the identification of genes expressed from the parental source of EVs, as well as the measuring of the abundance of specific transcripts, facilitating insight into the role played by EVs in health and disease. In addition, RNA sequencing serves to determine the amount of mRNA and non-coding RNA present in EVs, as well as to study post-transcriptional modifications of mRNA. These types of profiling can be used to identify biomarkers for diseases associated with EVs, examine the role of EVs in disease progression, and identify novel therapeutic targets and mechanisms.
Fig.1 sEV biogenesis, cargo contents and uptake.1
RNA sequencing services for EVs provide important insights into the nature of RNA cargo based on the intercellular transfer of EVs, contributing to the elucidation of the mechanisms by which EVs interact with their environment as well as the molecular mechanisms associated with their potential regulatory and therapeutic effects. Creative Biolabs offers the following RNA sequencing services for EVs, among others:
RNA Sequencing Procedures as below,
RNA sequencing for EVs supports the exploration of the molecular composition of EVs and the biological processes they are involved in, helping to better understand the mechanisms of EV-mediated communication between cells and tissues, which can be used to develop new diagnostic and therapeutic approaches. Creative Biolabs offers RNA sequencing services with an innovative molecular analysis platform for EVs. Please contact us with your demands.
A: Our service can analyze a wide range of RNA types including mRNA, microRNA (miRNA), long non-coding RNA (lncRNA), and small interfering RNA (siRNA) among others, depending on the customer's specific needs and sample preparation.
A: The isolation of EVs depends on the sample source and the downstream application, but common techniques include ultracentrifugation, size-exclusion chromatography, and immunoaffinity capture. We can tailor the isolation method to match the RNA that is being targeted or the customer's specific requirements.
A: Our preparation starts with isolating high-quality RNA from EVs. This is followed by DNase treatment to remove DNA contaminants, RNA cleanup, and quantification. We can provide sample preparation services or guide you through the process if you prefer to handle it in-house.
A: After sequencing, data is processed through a pipeline that involves quality control, alignment to a reference genome or transcriptome, and quantification of transcript abundances. We can offer differential expression analysis, pathway analysis, and more, depending on your research objectives. We can help with the understanding of the outcomes and offer customization options for the data analysis.
A: One limitation can be the low abundance of RNA in some EV samples. Additionally, the small size of some RNA species (e.g., miRNA) can sometimes pose challenges in library preparation and sequencing. Our skilled team and well-optimized processes, however, are prepared to tackle these difficulties.
Reference